Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1 1

Status

Recruiting 3Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 6INDUSTRY 3

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Breast Neoplasms 7244Neoplasms 4539Prostatic Neoplasms 3489Colorectal Neoplasms 2940Carcinoma, Non-Small-Cell Lung 2831Lung Neoplasms 2547Leukemia, Myeloid, Acute 1982Pancreatic Neoplasms 1874Multiple Myeloma 1811Carcinoma, Hepatocellular 1733Neoplasm Metastasis 1585Stomach Neoplasms 1502Lymphoma 1457Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Head and Neck Neoplasms 1435Brain Neoplasms 1373Melanoma 1348Ovarian Neoplasms 1342Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1138Uterine Cervical Neoplasms 1096Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 932Squamous Cell Carcinoma of Head and Neck 921

Interventions

folfirinox 1Oxaliplatin 1Neoadjuvant Therapy 1Leucovorin 1Irinotecan 1FAPI-46 1Endosonography 1Blood Specimen Collection 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Interventional × Pancreatic Ductal Adenocarcinoma (PDAC) × Clear all
NCT07561463 2026-05-01

Sacituzumab Tirumotecan for Pancreatic Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
30 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT06659705 2026-04-15

INDIGO-FAPI

Institut Curie

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT04990609 2025-05-21

EUS-RFA PANCARDINAL-1 Trial

The University of Texas Health Science Center, Houston

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT06967662 2025-05-16

INTRACOR_pilot

Ilyinskaya Hospital, JSC

Phase NA Enrolling by invitation
28 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT04575363 2023-11-09

PaCaBioMarkeR

CHU de Reims

Phase NA Recruiting
90 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT02782182 2019-03-19

Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study

University of Chicago

Phase 1 Terminated
1 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡